SCHEDULE 13G: Key Executive LinLin Qian Discloses Significant 24.4% Stake in Health In Tech, Inc. Post-IPO

LinLin Qian, an individual, has disclosed a beneficial ownership of 24.4% of Health In Tech, Inc.'s Class A Common Stock as of December 31, 2024, comprising a mix of common shares, restricted stock, Class B shares, and stock options.

Summary

• LinLin Qian beneficially owns an aggregate of 11,433,065 shares of Health In Tech, Inc.'s Class A Common Stock, representing 24.4% of the class.
• The ownership includes 7,901,465 shares of Class A Common Stock.
• It also includes 82,500 restricted shares of Class A Common Stock, which are set to vest on June 24, 2025.
• An additional 37,590 restricted shares of Class A Common Stock will vest in equal quarterly installments over two years following the issuer's initial public offering.
• The stake comprises 2,700,000 shares of Class B Common Stock, each convertible into one share of Class A Common Stock.
• LinLin Qian holds 495,000 options to purchase Class A Common Stock, vesting on June 24, 2025.
• Further, 170,115 options to purchase Class A Common Stock are included, with one-third vested upon the IPO on December 24, 2024, and the remainder vesting quarterly over two years.
• Finally, 46,395 options to purchase Class A Common Stock vested upon the initial public offering on December 24, 2024.
• The percentage ownership is calculated based on 42,369,358 shares of Class A Common Stock outstanding, 1,145,182 shares of restricted stock outstanding, and an aggregate of 3,411,510 shares (Class B Common Stock and options) deemed outstanding for the reporting person's calculation.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment. The high insider ownership could be viewed positively, but the filing itself is purely informational.

Positives

• The significant beneficial ownership of 24.4% by LinLin Qian, a key individual, indicates strong insider alignment with shareholder interests.
• A substantial portion of the beneficial ownership is comprised of directly held Class A Common Stock and convertible Class B Common Stock, providing direct equity exposure.

Risks

• A significant portion of the beneficial ownership, including restricted shares and stock options, is subject to vesting conditions tied to LinLin Qian's continued service with the issuer, posing a risk if service is discontinued.
• The conversion of Class B Common Stock and exercise of options could lead to dilution for existing Class A shareholders if not properly managed.

Future Outlook

A significant portion of LinLin Qian's beneficial ownership, including 120,090 restricted shares and 665,115 options, is subject to future vesting schedules, with key vesting dates in June 2025 and ongoing quarterly installments over the next two years. This implies potential future increases in the publicly traded Class A Common Stock float as these awards vest and become exercisable/convertible.

Management Comments

• The filing reflects the significant ownership stake of LinLin Qian, a key individual associated with Health In Tech, Inc., demonstrating a substantial personal investment in the company's equity.

Industry Context

This Schedule 13G filing is a routine disclosure of beneficial ownership by a significant shareholder, likely an insider, following the company's initial public offering. It provides transparency regarding the ownership structure of Health In Tech, Inc. within the broader health technology sector, indicating strong insider commitment post-IPO.

Stakeholder Impact

• Shareholders: High insider ownership may signal confidence in the company's future, potentially aligning management's interests with those of public shareholders. However, future vesting and conversion could lead to dilution.
• Employees: The vesting conditions tied to continued service for restricted shares and options highlight the importance of key personnel retention.

Next Steps

• Monitoring the vesting of LinLin Qian's restricted shares and stock options on June 24, 2025, and subsequent quarterly vesting periods.
• Observing any potential conversion of Class B Common Stock into Class A Common Stock by LinLin Qian.

Key Dates

Keywords

Health In Tech, LinLin Qian, SEC filing, Schedule 13G, beneficial ownership, Class A Common Stock, Class B Common Stock, stock options, restricted stock, equity incentive plan, IPO, insider ownership